Literature DB >> 11709290

Priming of human neutrophils by mycobacterial lipoarabinomannans: role of granule mobilisation.

J Fäldt1, C Dahlgren, M Ridell, A Karlsson.   

Abstract

Lipoarabinomannans (LAMs) from mycobacteria were investigated concerning their effect on human neutrophils. Two types of LAM, the mannose-capped ManLAM from the virulent Mycobacterium tuberculosis H37Rv and the mannose-lacking AraLAM from a rapidly growing mycobacterial strain were used. Neither AraLAM nor ManLAM induced any significant direct activation of the NADPH-oxidase. Both LAMs, however, primed the neutrophils so that subsequent stimulation with the peptide chemoattractants fMet-Leu-Phe (fMLF), Trp-Lys-Tyr-Met-Val-DMet (WKYMVm) and the mammalian lactose-binding lectin galectin-3 resulted in a markedly enhanced oxidative response. The LAM-induced priming was accompanied by an increased exposure of complement receptors 1 and 3 as well as the formyl peptide receptor on the neutrophil surface, suggesting that the enhanced oxidative response could be due to upregulation of receptors on the cell surface as a result of granule mobilisation. Since LAM-primed neutrophils released 65% of the cell content of gelatinase but showed no increased release of vitamin B(12)-binding protein, mobilisation of the gelatinase granules rather than the specific granules is concluded to be responsible for the priming effects. This is in agreement with the subcellular localisation of receptors for fMLF, WKYMVm, as well as galectin-3, which are stored in the secretory vesicles and gelatinase granules. The priming effect appeared very similar to that of Escherichia coli lipopolysaccharide, and since no differences in activity could be detected between AraLAM and ManLAM, we hypothesize that the lipid anchor of the LAM is responsible for the priming effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709290     DOI: 10.1016/s1286-4579(01)01470-8

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

1.  CFP-10 from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor.

Authors:  Amanda Welin; Halla Björnsdottir; Malene Winther; Karin Christenson; Tudor Oprea; Anna Karlsson; Huamei Forsman; Claes Dahlgren; Johan Bylund
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

2.  The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.

Authors:  Huamei Fu; Johan Bylund; Anna Karlsson; Sara Pellmé; Claes Dahlgren
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

Review 3.  Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane.

Authors:  Jamel El-Benna; Pham My-Chan Dang; Marie-Anne Gougerot-Pocidalo
Journal:  Semin Immunopathol       Date:  2008-06-07       Impact factor: 9.623

4.  Exocytosis of neutrophil granule subsets and activation of prolyl isomerase 1 are required for respiratory burst priming.

Authors:  Kenneth R McLeish; Silvia M Uriarte; Shweta Tandon; Timothy M Creed; Junyi Le; Richard A Ward
Journal:  J Innate Immun       Date:  2013-01-26       Impact factor: 7.349

Review 5.  Multiple Phenotypic Changes Define Neutrophil Priming.

Authors:  Irina Miralda; Silvia M Uriarte; Kenneth R McLeish
Journal:  Front Cell Infect Microbiol       Date:  2017-05-29       Impact factor: 5.293

Review 6.  The Sweet-Side of Leukocytes: Galectins as Master Regulators of Neutrophil Function.

Authors:  Brian S Robinson; Connie M Arthur; Birk Evavold; Ethan Roback; Nourine A Kamili; Caleb S Stowell; Mary L Vallecillo-Zúniga; Pam M Van Ry; Marcelo Dias-Baruffi; Richard D Cummings; Sean R Stowell
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 8.786

7.  Live Vaccines Have Different NK Cells and Neutrophils Requirements for the Development of a Protective Immune Response Against Tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Monalisa Martins Trentini; Lázaro Moreira Marques Neto; André Kipnis
Journal:  Front Immunol       Date:  2020-04-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.